Palex Medical SA has acquired Grupo Taper
Palex Medical SA, a leading distributor of medical equipment in Spain and Portugal, has acquired the healthcare business of Grupo Taper, with the objective to strengthen its position as a distributor company within the hospitality sector. Financial details have not been disclosed.
Founded in 1955, Palex Medical has three divisions: the hospital division that serves the needs of hospitals, clinics, medical centers and private practices; the lab and research division specializes in complete, integrated solutions for all types of anatomical pathology labs, research and diagnostic laboratories; and the specialty clinics division providing image diagnosis services.
Founded in 1989, Grupo Taper is a Spanish company that distributes equipment and products for medical centers, pathological anatomy labs, investigation and diagnosis for the food industry.
Oaklins' team in Spain advised the buyer in this transaction.


Talk to the deal team
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more